The Sanguine Journal
Press
Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.
Interested in participating?
Join the Sanguine donor community and get matched to studies that fit your health profile and location.


